Combined effects of DHEA and fadrozole on aggression and neural VIP immunoreactivity in the non-breeding male song sparrow.
The male Song Sparrow, Melospiza melodia morphna, shows high levels of aggression in its non-breeding season, concomitant with basal levels of circulating testosterone (T) and estradiol (E(2)). However, administration of fadrozole, an aromatase inhibitor, decreases non-breeding aggression in the field. Circulating levels of dehydroepiandrosterone (DHEA), an androgen/estrogen precursor, correspond to the seasonal expression of aggression in this species, with high levels in the breeding and non-breeding seasons when aggression is also high, and lower levels during the molt when aggression is low. We test the hypothesis that circulating DHEA up-regulates non-breeding aggression via an aromatase-mediated mechanism. We also hypothesize that this up-regulation of aggression is partially mediated by changes in vasoactive intestinal polypeptide (VIP) in the lateral extent of the bed nucleus of the stria terminalis (BSTl) and lateral septum (LS). Birds were administered either DHEA, fadrozole, or both for 2 weeks and tested for aggression in a lab-based paradigm. As predicted, birds given DHEA were significantly more aggressive. However, fadrozole did not block this effect, and, when administered without DHEA, also led to increased aggression over controls. These results may be explained by the fact that the behaviors measured in field tests, which include more direct attack behaviors, may be under different hormonal regulation than the behaviors measured in the lab paradigm, which represent warning, or threat, behaviors. VIP immunoreactivity (VIP-ir) changed across multiple brain regions with this treatment regimen, most notably in the LSO/VFI subdivision of the lateral septum.
Wacker
Douglas W
DW
Graduate Program in Neurobiology and Behavior, Department of Biology, Box 351800, University of Washington, Seattle, WA 98195, USA. dwacker@u.washington.edu
Schlinger
Barney A
BA
Wingfield
John C
JC
D000374:Aggression / Q000187:drug effects* / Q000502:physiology; D000704:Analysis of Variance; D000728:Androgens / Q000494:pharmacology; D000818:Animals; D047072:Aromatase Inhibitors / Q000494:pharmacology*; D003687:Dehydroepiandrosterone / Q000494:pharmacology*; D004347:Drug Interactions; D004958:Estradiol / Q000097:blood; D017316:Fadrozole / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects; D007150:Immunohistochemistry; D008297:Male; D012098:Reproduction / Q000502:physiology; D012686:Septal Nuclei / Q000187:drug effects / Q000378:metabolism; D020665:Septum of Brain / Q000378:metabolism*; D012931:Social Environment; D018709:Statistics, Nonparametric; D013739:Testosterone / Q000097:blood; D014018:Tissue Distribution; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism*
D000728:Androgens; D047072:Aromatase Inhibitors; D014660:Vasoactive Intestinal Peptide; D013739:Testosterone; D003687:Dehydroepiandrosterone; D004958:Estradiol; D017316:Fadrozole